BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21707454)

  • 1. Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management.
    Spiliotis J; Halkia E; Roukos DH
    Expert Rev Mol Diagn; 2011 Jun; 11(5):465-7. PubMed ID: 21707454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening pelvic tumours for hereditary risk of ovarian neoplasms, a cancer center experience].
    Taïeb S; Rocourt N; Narducci F; Leblanc E; Adenis C; Fournier C; Doutrelant P; Peyrat JP; Vennin P
    Bull Cancer; 2011 Feb; 98(2):113-9. PubMed ID: 21339094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 4. A doctor talks about. Screening for ovarian cancer.
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Sep; 12(1):5. PubMed ID: 15381472
    [No Abstract]   [Full Text] [Related]  

  • 5. Women with symptoms of ovarian cancer should have a CA125 test, says NICE.
    Gulland A
    BMJ; 2011 Apr; 342():d2695. PubMed ID: 21525103
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 7. CA 125: Value or addiction?
    Goldman PA
    Cancer; 2010 Jun; 116(12):2854-5. PubMed ID: 20564391
    [No Abstract]   [Full Text] [Related]  

  • 8. The Hunt Continues for Early Ovarian Cancer Clues.
    Kuehn BM
    JAMA; 2017 Jul; 318(1):14-16. PubMed ID: 28614574
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A step forward for two-step screening for ovarian cancer.
    Hensley ML
    J Clin Oncol; 2010 May; 28(13):2128-30. PubMed ID: 20368556
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.
    Vuento MH; Stenman UH; Pirhonen JP; Mäkinen JI; Laippala PJ; Salmi TA
    Gynecol Oncol; 1997 Jan; 64(1):141-6. PubMed ID: 8995563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.
    Xu JL; Commins J; Partridge E; Riley TL; Prorok PC; Johnson CC; Buys SS
    Gynecol Oncol; 2012 Apr; 125(1):70-4. PubMed ID: 22198243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal carcinosis in ovarian cancer: conventional imaging (CT-scan and MRI)].
    Bailly C; Bailly-Glatre A; Alfidja A; Vincent C; Dauplat J; Pomel C
    Bull Cancer; 2009 Dec; 96(12):1155-62. PubMed ID: 19959422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor marker in ovarian cancer].
    Komai K; Nishida T
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is it possible to have organized screening for ovarian cancer?].
    Navone R; Montanari G
    Pathologica; 2003 Apr; 95(2):67-70. PubMed ID: 12768874
    [No Abstract]   [Full Text] [Related]  

  • 17. HE4 in ovarian cancer: from discovery to clinical application.
    Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
    Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic-peritoneal tuberculosis simulating peritoneal carcinomatosis: high clinical suspicion and a minimally invasive procedure.
    Adali E; Dulger C; Kolusari A; Kurdoglu M; Yildizhan R
    Arch Gynecol Obstet; 2009 Nov; 280(5):867-8. PubMed ID: 19565253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the early detection of ovarian cancer: How to hear the whispers early.
    Cesario S
    Nurs Womens Health; 2010 Jun; 14(3):222-34. PubMed ID: 20579298
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovarian cancer biomarker screening: still too early to tell.
    Anderson GL
    Womens Health (Lond); 2010 Jul; 6(4):487-90. PubMed ID: 20597610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.